DXCM (DexCom) Beginning Cash Position: $919 Mil (As of Mar. 2026)


DXCM DexCom Inc DXCM
94 GF Score
Price $73.57
GF Value $104.00
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Beginning Cash Position?

DexCom DXCM +1.64% 94 Beginning Cash Position is $919 Mil as of Mar. 2026. GuruFocus rates DXCM with a GF Score™ of 94/100 and a GF Value™ of $104.00 (Modestly Undervalued). The stock has 3 warning signs investors should review.

DexCom's Beginning Cash Position for the quarter that ended in Mar. 2026 was $919 Mil.

DexCom's quarterly Beginning Cash Position increased from Sep. 2025 ($1,160 Mil) to Dec. 2025 ($1,837 Mil) but then declined from Dec. 2025 ($1,837 Mil) to Mar. 2026 ($919 Mil).

DexCom's annual Beginning Cash Position declined from Dec. 2023 ($643 Mil) to Dec. 2024 ($568 Mil) but then increased from Dec. 2024 ($568 Mil) to Dec. 2025 ($607 Mil).

DexCom Beginning Cash Position Related Terms

DexCom Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for DexCom's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom Beginning Cash Position Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 818.20 1,053.60 643.30 567.50 607.30

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 607.30 906.10 1,160.30 1,836.90 919.10
DXCM
94GF Score
DexCom Inc DXCM
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $919 Mil mean?
DexCom (DXCM) has a Beginning Cash Position of $919 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on DexCom and its competitors.
Is DexCom's Beginning Cash Position too high?
DexCom's current Beginning Cash Position is $919 Mil. Overall, DexCom has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Beginning Cash Position compare to GEHC and STE?
DexCom's Beginning Cash Position of $919 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on DexCom and its competitors. DexCom's current Beginning Cash Position is $919 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Modestly Undervalued. The stock's GF Value™ is $104.00, compared to a current price of $73.57 — trading 29.3% below its estimated fair value. The current Beginning Cash Position is $919 Mil. DexCom's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For DexCom (DXCM), the current Beginning Cash Position is $919 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of $73.57 is trading 29.3% below its estimated GF Value™ of $104.00. GuruFocus considers DexCom to be Modestly Undervalued.

Key valuation signals for DXCM:

  • Beginning Cash Position: $919 Mil
  • GF Value™: $104.00 vs. price of $73.57 (29.3% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
94GF Score

Get the complete analysis for DXCM

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.57
Price
$104.00
GF Value